First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL
The study findings add new insights, but also raise new questions, about the best treatment approach for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Medscape Medical News
source https://www.medscape.com/viewarticle/989065?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/989065?src=rss
Comments
Post a Comment